FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
Glioma is the most common primary brain tumor. Filamin-binding LIM protein 1 (FBLIM1) has been identified in multiple cancers and is suspected of playing a part in the development of tumors. However, the potential function of FBLIM1 mRNA in glioma has not been investigated. In this study, the clinic...
Main Authors: | Deng Yifan, Zeng Kailiang, Wu Diancheng, Ling Yunzhi, Tian Yu, Zheng Yi, Fang Shumin, Jiang Xiaocong, Zhu Gang, Tu Yanyang |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-12-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0863 |
Similar Items
-
circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346
by: Ning Bai, et al.
Published: (2018-07-01) -
High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO)
by: Adamo Pio d’Adamo, et al.
Published: (2020-07-01) -
Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma
by: Bing-Yan Tao, et al.
Published: (2022-05-01) -
Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
by: Xiaoyue Ren, et al.
Published: (2023-08-01) -
MELK is a prognostic biomarker and correlated with immune infiltration in glioma
by: Haiyan Yang, et al.
Published: (2022-10-01)